Related Experiment Videos

Nonsteroidal anti-inflammatory drugs and oxidative stress in cancer cells

M Adachi1, H Sakamoto, R Kawamura

  • 1First Department of Internal Medicine, Graduate School of Medicine, Sapporo Medical University, Sapporo, Japan. adachi@sapmed.ac.jp

Histology and Histopathology
|February 10, 2007
PubMed

Insights

Nonsteroidal anti-inflammatory drugs (NSAIDs) show anticancer effects by inducing cancer cell apoptosis. Increased reactive oxygen species (ROS) generation is proposed as a key mechanism for these effects.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Nonsteroidal anti-inflammatory drugs (NSAIDs) demonstrate apoptosis-inducing properties in various cancer cell types, including colon, prostate, breast, and leukemia.
  • NSAIDs like sulindac and aspirin are recognized for their chemopreventive potential, particularly against colon cancer.

Purpose of the Study:

  • To elucidate the precise mechanisms by which NSAIDs induce cell cycle arrest and apoptosis in cancer cells.
  • To investigate the selectivity of NSAIDs' anticancer effects, a critical factor for therapeutic application.

Main Methods:

  • Review of existing literature on NSAID mechanisms in cancer.
  • Analysis of NSAID-induced biological effects, including cyclooxygenase (COX) inhibition, reactive oxygen species (ROS) generation, and NF-kappaB signaling inhibition.

Main Results:

  • NSAIDs inhibit cyclooxygenases (COX), thereby reducing prostaglandin, prostacyclin, and thromboxane synthesis.
  • NSAIDs also induce other biological effects, such as reactive oxygen species (ROS) generation and inhibition of NF-kappaB-mediated signals.

Conclusions:

  • Increased generation of reactive oxygen species (ROS) is proposed as a primary mechanism underlying the anticancer effects of NSAIDs across diverse cancer cell types.
  • Further understanding of NSAID anticancer mechanisms and selectivity is crucial for advancing cancer therapy.

Related Concept Videos

Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...